Omeprazole Capsule, Delayed Release
Product Images NDC 21130-783

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Omeprazole (NDC 21130-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safeway, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Signature-select-omeprazole-carton-image-1.jpg (Signature Select Omeprazole Carton Image 1)

Signature-select-omeprazole-carton-image-1.jpg (Signature Select Omeprazole Carton Image 1)
This is a description of Omeprazole delayed-release capsules in 20mg strength. It is an acid reducer providing 24-hour relief. Each package contains 42 capsules, the equivalent of three 14-day treatment courses. It may take 1 to 4 days to achieve full effectiveness. The product is compared to Prilosec OTC. The signature on the package indicates it may be a part of the SELECTâ„¢ line. The safety feature includes not using it if the printed foil seal under the cap is broken or missing.*
FDA Label Image

Signature-select-omeprazole-carton-image-2.jpg (Signature Select Omeprazole Carton Image 2)

Signature-select-omeprazole-carton-image-2.jpg (Signature Select Omeprazole Carton Image 2)
This document contains detailed information about a medication, specifically Omeprazole delayed-release capsules. It provides instructions on usage, dosage, warnings, and inactive ingredients. The drug is intended for adults aged 18 years and older to treat heartburn occurring twice a week or more frequently. The text also includes information on potential side effects, overdose procedures, and precautions for pregnant or breastfeeding individuals. Instructions on storage, dosage frequency, and the duration of treatment are outlined in the document as well. The medicine is manufactured by Better Living Brands LLC in Israel and distributed by Procter & Gamble.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.